|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14-12-09 | Cubist Pharmaceuticals : sales force seen as potential boon for Merck intestinal drug | RE |
| 14-12-09 | Cubist Pharmaceuticals : Merck says still plans to buy Cubist, despite patent setback | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -1.87% | +4.22% | +7.20% | +30.26% | +7.24% | +44.36% | +1.14% | +21.80% | +107.81% | 82.65B | |
| -0.57% | +1.27% | +33.55% | +78.22% | +1.07% | -16.61% | -35.57% | -42.57% | +66.32% | 60.24B | |
| -2.23% | +5.48% | +170.24% | +206.81% | +393.56% | +478.96% | +34.47% | -65.07% | - | 58.11B | |
| -2.03% | -2.62% | -2.95% | +7.99% | -14.63% | -8.63% | +27.87% | -1.04% | - | 49.68B | |
| -4.58% | -2.73% | -6.40% | -19.31% | -11.74% | +1.79% | +155.89% | +114.20% | +184.06% | 46.66B | |
| -1.64% | +1.07% | +7.05% | +13.05% | +25.48% | +56.98% | -16.26% | -33.80% | -28.92% | 32.63B | |
| -0.98% | +1.91% | +7.07% | +23.80% | +28.33% | +46.30% | +100.59% | +66.58% | +51.34% | 25.69B | |
| -0.19% | -4.74% | +13.40% | +33.68% | +34.30% | -0.68% | +194.68% | +55.03% | - | 22.73B | |
| -1.13% | -2.45% | +3.18% | +1.84% | +36.66% | +64.66% | +108.24% | +87.01% | +348.96% | 16.54B | |
| +1.94% | -9.84% | +4.15% | +12.80% | -16.56% | -21.13% | +779.37% | +428.86% | +6,650.90% | 14.92B | |
| -0.76% | -2.30% | -9.61% | +10.69% | -2.16% | +40.20% | +153.78% | +44.98% | - | 14.63B | |
| +0.15% | +2.88% | +8.25% | +17.19% | +11.95% | +15.16% | -26.89% | -21.68% | -30.40% | 12.88B | |
| -0.80% | +3.85% | -1.64% | -11.04% | +13.16% | +65.12% | +153.50% | +674.37% | +2,754.70% | 10.83B | |
| -3.56% | +1.93% | +11.02% | +19.02% | +45.31% | +138.40% | +188.90% | +511.64% | - | 10.6B | |
| -3.10% | -11.78% | +14.34% | +80.18% | +293.19% | +384.16% | +407.20% | +8.73% | - | 7.82B | |
| -0.34% | -0.56% | -3.10% | +9.23% | -7.53% | -19.56% | -21.45% | -52.71% | -48.63% | 6.88B | |
| -1.89% | -0.40% | -0.43% | +28.44% | +2.98% | -6.38% | +68.55% | -12.56% | - | 6.21B | |
| -3.18% | -0.22% | +1.83% | +60.90% | +88.87% | +118.17% | +350.87% | +532.39% | - | 6.08B | |
| +0.31% | -0.96% | -1.84% | +10.77% | +2.62% | -0.76% | +220.23% | +202.33% | - | 5.63B | |
| Average | -1.39% | -0.73% | +13.44% | +32.34% | +49.06% | +72.66% | +149.74% | +132.55% | +1,005.61% | 24.57B | |
| Weighted average by Cap. | -1.66% | +0.35% | +26.55% | +45.80% | +58.03% | +82.29% | +83.26% | +56.03% | +503.20% |
- Stock Market
- Stocks
- Stock
- Sector Cubist Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
